A novel functional outcome measure for early-onset Charcot-Marie-Tooth disease

Takeaway 

  • A robust functional outcome measure for Charcot–Marie–Tooth disease (CMT) in infants and children has been developed and validated.

Why this matters

    Use of validated clinical trial outcome measures for CMT during infancy and childhood provide an opportunity to treat the disease prior to the onset of long-term disability.